Health & Fitness
Thu, September 30, 2010Wed, September 29, 2010Tue, September 28, 2010Mon, September 27, 2010Sun, September 26, 2010Sat, September 25, 2010Fri, September 24, 2010Thu, September 23, 2010Wed, September 22, 2010Tue, September 21, 2010Mon, September 20, 2010Fri, September 17, 2010Thu, September 16, 2010Wed, September 15, 2010Tue, September 14, 2010Mon, September 13, 2010Sun, September 12, 2010Fri, September 10, 2010Thu, September 9, 2010Exact Sciences to Present at JMP Securities Healthcare Conference
Published in Health and Fitness on Tuesday, September 21st 2010 at 4:45 GMT by Market Wire
MADISON, Wis.--([ BUSINESS WIRE ])--Exact Sciences Corp. (Nasdaq: EXAS) today announced that it will present at the JMP Securities Healthcare Conference, which is being held Sept. 27-28, 2010, at the New York Palace Hotel in New York.
Kevin T. Conroy, Exacta™s president and chief executive, will make the companya™s presentation on Monday, Sept. 27 at 8:30 a.m. Eastern Time. A live webcast of the presentation will be available through the companya™s website at [ www.exactsciences.com ]. An archived webcast will be available following the conclusion of the conference.
About Exact Sciences Corp.
Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Stool-based DNA technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer. For more information, please visit the companya™s website at [ www.exactsciences.com ].
Certain statements made in this presscontain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, that are intended to be covered by the asafe harbora created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as abelieve,a aexpect,a amay,a awill,a ashould,a acould,a aseek,a aintend,a aplan,a aestimate,a aanticipatea or other comparable terms. Forward-looking statements in thispress releasemay address the following subjects among others: statements regarding the sufficiency of our capital resources, expected operating losses, expected license fee revenues, expected research and development expenses, expected general and administrative expenses and our expectations concerning our business strategy. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, as a result of various factors including those risks and uncertainties described in the Risk Factors and in Managementa™s Discussion and Analysis of Financial Condition and Results of Operations sectionsof ourmost recently filedAnnual Report on Form 10-Kand oursubsequently filedQuarterly Reports on Form 10-Q. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
